Filing Details
- Accession Number:
- 0001104659-22-124100
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-02 16:14:02
- Reporting Period:
- 2022-11-30
- Accepted Time:
- 2022-12-02 16:14:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429260 | Fortress Biotech Inc. | FBIO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1930732 | David Jin | C/O Fortress Biotech, Inc. 1111 Kane Concourse Suite 301 Bay Harbor Islands FL 33154 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2022-11-30 | 5,000 | $0.56 | 1,402,829 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period. Under the ESPP, 5,000 shares is the maximum amount an individual employee may purchase during an offering period.
- The total holdings include 1,350,000 shares underlying restricted stock units.
Billionaire Hedge Funds
